Luned Badder

1.0k total citations
8 papers, 297 citations indexed

About

Luned Badder is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Luned Badder has authored 8 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Luned Badder's work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and DNA Repair Mechanisms (2 papers). Luned Badder is often cited by papers focused on Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and DNA Repair Mechanisms (2 papers). Luned Badder collaborates with scholars based in United Kingdom, United States and Australia. Luned Badder's co-authors include Karl Morten, Helen J. Knowles, Christopher J. Lord, Andrew Tutt, Rebecca Marlow, Eleanor Knight, Shudong Li, Daniel Weekes, Jiří Bártek and Yves Pommier and has published in prestigious journals such as Nature, Nature Cell Biology and The Journal of Physiology.

In The Last Decade

Luned Badder

7 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luned Badder United Kingdom	6	221	113	52	50	33	8	297
Sara Nik United States	10	456 2.1×	132 1.2×	69 1.3×	110 2.2×	38 1.2×	10	590
Hunter D. Reavis United States	7	157 0.7×	124 1.1×	16 0.3×	34 0.7×	22 0.7×	14	264
Agata Rozanska United Kingdom	14	556 2.5×	113 1.0×	25 0.5×	45 0.9×	22 0.7×	16	611
Maria Pia Gentileschi Italy	9	238 1.1×	183 1.6×	37 0.7×	57 1.1×	39 1.2×	15	379
Roberta Ferretti Italy	11	285 1.3×	54 0.5×	68 1.3×	38 0.8×	55 1.7×	14	392
Abdullah H. Feroze United States	6	165 0.7×	120 1.1×	21 0.4×	44 0.9×	27 0.8×	9	320
Igor I. Doronin Russia	8	264 1.2×	157 1.4×	16 0.3×	69 1.4×	82 2.5×	18	465
Kelly Arndt United States	10	255 1.2×	43 0.4×	45 0.9×	40 0.8×	21 0.6×	17	378
Luca Caputo United States	8	375 1.7×	23 0.2×	65 1.3×	50 1.0×	19 0.6×	10	419
Yimeng Zhu China	10	188 0.9×	67 0.6×	78 1.5×	36 0.7×	23 0.7×	22	358

Countries citing papers authored by Luned Badder

Since Specialization

Citations

This map shows the geographic impact of Luned Badder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luned Badder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luned Badder more than expected).

Fields of papers citing papers by Luned Badder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luned Badder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luned Badder. The network helps show where Luned Badder may publish in the future.

Co-authorship network of co-authors of Luned Badder

This figure shows the co-authorship network connecting the top 25 collaborators of Luned Badder. A scholar is included among the top collaborators of Luned Badder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luned Badder. Luned Badder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Badder, Luned, et al.. (2024). The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent “in-tumour” chemotherapy to pancreatic ductal adenocarcinoma. British Journal of Cancer. 131(10). 1694–1706.

2.

Bliss, Carly M., Sarah L. Hulin-Curtis, James A. Davies, et al.. (2024). A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications. Molecular Therapy — Methods & Clinical Development. 32(3). 101308–101308. 3 indexed citations

3.

Krastev, Dragomir B., Shudong Li, Yilun Sun, et al.. (2022). The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. Nature Cell Biology. 24(1). 62–73. 92 indexed citations

4.

Davies, James A., Gareth Marlow, Hanni Uusi-Kerttula, et al.. (2021). Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses. 13(5). 864–864. 10 indexed citations

5.

Lambrus, Bramwell G., Rebecca Marlow, Phillip M. Scott, et al.. (2020). Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. Nature. 585(7825). 447–452. 77 indexed citations

6.

Potter, Michelle, et al.. (2016). Monitoring Intracellular Oxygen Concentration: Implications for Hypoxia Studies and Real-Time Oxygen Monitoring. Advances in experimental medicine and biology. 876. 257–263. 5 indexed citations

7.

Kemp, Paul J., David J. Rushton, Polina Yarova, et al.. (2016). Improving and accelerating the differentiation and functional maturation of human stem cell‐derived neurons: role of extracellular calcium and GABA. The Journal of Physiology. 594(22). 6583–6594. 35 indexed citations

8.

Morten, Karl, Luned Badder, & Helen J. Knowles. (2013). Differential regulation of HIF‐mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. The Journal of Pathology. 229(5). 755–764. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact